Table of Contents

1 Study Coverage

• 1.1 Bulk Drug Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Bulk Drug Market Size Growth Rate by Product
  • 1.4.2 Vitamin
  • 1.4.3 Antibiotic
  • 1.4.4 Iohexol
  • 1.4.5 Hormone
  • 1.4.6 Amino Acid
• 1.5 Market by End User
  • 1.5.1 Global Bulk Drug Market Size Growth Rate by End User
  • 1.5.2 Orthopedics Disease
  • 1.5.3 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Bulk Drug Market Size
  • 2.1.1 Global Bulk Drug Revenue 2014-2025
  • 2.1.2 Global Bulk Drug Sales 2014-2025
• 2.2 Bulk Drug Growth Rate by Regions
  • 2.2.1 Global Bulk Drug Sales by Regions
  • 2.2.2 Global Bulk Drug Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Bulk Drug Sales by Manufacturers
  • 3.1.1 Bulk Drug Sales by Manufacturers
  • 3.1.2 Bulk Drug Sales Market Share by Manufacturers
  • 3.1.3 Global Bulk Drug Market Concentration Ratio (CR5 and HHI)
• 3.2 Bulk Drug Revenue by Manufacturers
  • 3.2.1 Bulk Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Bulk Drug Revenue Share by Manufacturers (2014-2019)
• 3.3 Bulk Drug Price by Manufacturers
• 3.4 Bulk Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 Bulk Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Bulk Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into Bulk Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Bulk Drug Sales by Product
• 4.2 Global Bulk Drug Revenue by Product
• 4.3 Bulk Drug Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Bulk Drug Breakdown Data by End User

6 North America

• 6.1 North America Bulk Drug by Countries
  • 6.1.1 North America Bulk Drug Sales by Countries
  • 6.1.2 North America Bulk Drug Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Bulk Drug by Product
• 6.3 North America Bulk Drug by End User

7 Europe

• 7.1 Europe Bulk Drug by Countries
  • 7.1.1 Europe Bulk Drug Sales by Countries
  • 7.1.2 Europe Bulk Drug Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Bulk Drug by Product
• 7.3 Europe Bulk Drug by End User

8 Asia Pacific

• 8.1 Asia Pacific Bulk Drug by Countries
  • 8.1.1 Asia Pacific Bulk Drug Sales by Countries
  • 8.1.2 Asia Pacific Bulk Drug Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Bulk Drug by Product
• 8.3 Asia Pacific Bulk Drug by End User

9 Central & South America

• 9.1 Central & South America Bulk Drug by Countries
  • 9.1.1 Central & South America Bulk Drug Sales by Countries
  • 9.1.2 Central & South America Bulk Drug Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Bulk Drug by Product
• 9.3 Central & South America Bulk Drug by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Bulk Drug by Countries
  • 10.1.1 Middle East and Africa Bulk Drug Sales by Countries
  • 10.1.2 Middle East and Africa Bulk Drug Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Bulk Drug by Product
• 10.3 Middle East and Africa Bulk Drug by End User

11 Company Profiles

• 11.1 Teva
  • 11.1.1 Teva Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Teva Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Teva Bulk Drug Products Offered
  • 11.1.5 Teva Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Novartis Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Novartis Bulk Drug Products Offered
  • 11.2.5 Novartis Recent Development
• 11.3 Pfizer
  • 11.3.1 Pfizer Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Pfizer Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Pfizer Bulk Drug Products Offered
  • 11.3.5 Pfizer Recent Development
• 11.4 Johnson & Johnson
  • 11.4.1 Johnson & Johnson Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Johnson & Johnson Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Johnson & Johnson Bulk Drug Products Offered
  • 11.4.5 Johnson & Johnson Recent Development
• 11.5 Mylan
  • 11.5.1 Mylan Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Mylan Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Mylan Bulk Drug Products Offered
  • 11.5.5 Mylan Recent Development
• 11.6 North China Pharmaceutical Group
  • 11.6.1 North China Pharmaceutical Group Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 North China Pharmaceutical Group Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 North China Pharmaceutical Group Bulk Drug Products Offered
  • 11.6.5 North China Pharmaceutical Group Recent Development
• 11.7 Dr. Reddy’s Laboratories
  • 11.7.1 Dr. Reddy’s Laboratories Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Dr. Reddy’s Laboratories Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Dr. Reddy’s Laboratories Bulk Drug Products Offered
  • 11.7.5 Dr. Reddy’s Laboratories Recent Development
• 11.8 Roche
  • 11.8.1 Roche Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Roche Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Roche Bulk Drug Products Offered
  • 11.8.5 Roche Recent Development
• 11.9 Aurobindo pharma
  • 11.9.1 Aurobindo pharma Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Aurobindo pharma Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Aurobindo pharma Bulk Drug Products Offered
  • 11.9.5 Aurobindo pharma Recent Development
• 11.10 Sun Pharmaceutical Industries
  • 11.10.1 Sun Pharmaceutical Industries Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Sun Pharmaceutical Industries Bulk Drug Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Sun Pharmaceutical Industries Bulk Drug Products Offered
  • 11.10.5 Sun Pharmaceutical Industries Recent Development
• 11.11 Boehringer Ingelheim GmbH
• 11.12 Bayer
• 11.13 BASF
• 11.14 DSM
• 11.15 Zhejiang Medicine
• 11.16 Biocon
• 11.17 Johnson Matthey
• 11.18 Hisun Pharmacy
• 11.19 Cambrex
• 11.20 Shandong Xinhua Pharmaceutical
• 11.21 Lonza group
• 11.22 Huahai Pharmaceutical
• 11.23 Haerbin Pharmaceutical Group

12 Future Forecast

• 12.1 Bulk Drug Market Forecast by Regions
  • 12.1.1 Global Bulk Drug Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Bulk Drug Revenue Forecast by Regions 2019-2025
• 12.2 Bulk Drug Market Forecast by Product
  • 12.2.1 Global Bulk Drug Sales Forecast by Product 2019-2025
  • 12.2.2 Global Bulk Drug Revenue Forecast by Product 2019-2025
• 12.3 Bulk Drug Market Forecast by End User
• 12.4 North America Bulk Drug Forecast
• 12.5 Europe Bulk Drug Forecast
• 12.6 Asia Pacific Bulk Drug Forecast
• 12.7 Central & South America Bulk Drug Forecast
• 12.8 Middle East and Africa Bulk Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Bulk Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Bulk Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bulk Drug market based on company, product type, end user and key regions.

This report studies the global market size of Bulk Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bulk Drug in these regions.
This research report categorizes the global Bulk Drug market by top players/brands, region, type and end user. This report also studies the global Bulk Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group

Market size by Product
Vitamin
Antibiotic
Iohexol
Hormone
Amino Acid
Market size by End User
Orthopedics Disease
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Bulk Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bulk Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bulk Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bulk Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bulk Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bulk Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.